{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:22:48Z","timestamp":1790713368670,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.molmet.2021.101337","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T21:26:40Z","timestamp":1630963600000},"page":"101337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment"],"prefix":"10.1016","volume":"54","author":[{"given":"Nunzia","family":"D'Onofrio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino","family":"Sardu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Consiglia","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Scisciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Ferraraccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Panarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lella","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Modugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Massetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica Vittoria","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangela","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Furbatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Minicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molmet.2021.101337_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.molmet.2021.101337_bib2","article-title":"Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes","volume":"7","author":"Sugiyama","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.molmet.2021.101337_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","article-title":"Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA","volume":"20","author":"Paolisso","year":"2021","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.molmet.2021.101337_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116972","article-title":"The human kidney low af\ufb01nity Na+\/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose","volume":"93","author":"Kanai","year":"1994","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2021.101337_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diabetes and Vascular Disease Research"},{"key":"10.1016\/j.molmet.2021.101337_bib6","article-title":"SGLT2i: new perspectives in diabetes and kidney disease","volume":"25","author":"Ferrannini","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother Jan"},{"key":"10.1016\/j.molmet.2021.101337_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.molmet.2021.101337_bib8","first-page":"56","article-title":"Hollenberg, Hyperglycaemic impairment of PAR2-mediated vasodilation: prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress, Vasc","volume":"109","author":"El-Daly","year":"2018","journal-title":"Pharmacol"},{"key":"10.1016\/j.molmet.2021.101337_bib9","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1038\/s41598-018-25054-y","article-title":"High basolateral glucose increases sodium-glucose cotransporter 2 and reduces sirtuin-1 in renal tubules through glucose transporter-2 detection","volume":"8","author":"Umino","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2021.101337_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","article-title":"Cardioprotective effects of Sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (Sodium-Glucose Cotransporter 2) inhibitors","volume":"13","author":"Packer","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.molmet.2021.101337_bib11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/jcmm.14233","article-title":"Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence","volume":"24","author":"Khemais-Benkhiat","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.molmet.2021.101337_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143396","article-title":"Hirano, Amelioration of hyperglycemia with a sodium-glucose cotransporter 2 inhibitor prevents macrophage-driven atherosclerosis through macrophage foam cell formation suppression in type 1 and type 2 diabetic mice","volume":"10","author":"Terasaki","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2021.101337_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6305735","article-title":"The SGLT-2 inhibitor Dapagliflozin has a therapeutic effect on atherosclerosis in diabetic ApoE\u2212\/\u2212 mice","author":"Leng","year":"2016","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.molmet.2021.101337_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/db14-1149","article-title":"Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment","volume":"64","author":"Balestrieri","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2021.101337_bib15","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.STR.27.12.2216","article-title":"An analysis of perioperative surgical mortality and morbility in the Asymptomatic Carotid Atherosclerosis Study","volume":"27","author":"Young","year":"1996","journal-title":"Stroke"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2021.101337_bib16","first-page":"S14","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes","volume":"vol. 43","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2021.101337_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12872-019-1219-8","article-title":"The dating of thrombus organization in cases of pulmonary embolism: an autopsy study","volume":"19","author":"Mansueto","year":"2019","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.molmet.2021.101337_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijsu.2017.06.079","article-title":"Histological fibrosis may predict the failure of core decompression in the treatment of osteonecrosis of the femoral head","volume":"44","author":"Sadile","year":"2017","journal-title":"International Journal of Surgery"},{"key":"10.1016\/j.molmet.2021.101337_bib19","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jacc.2006.01.073","article-title":"Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment","volume":"47","author":"Marfella","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101337_bib20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jcp.29064","article-title":"MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients","volume":"235","author":"D'Onofrio","year":"2020","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101337_bib21","first-page":"162","article-title":"Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation Diabetologia","volume":"56","author":"Balestrieri","year":"2013"},{"key":"10.1016\/j.molmet.2021.101337_bib22","first-page":"1421","article-title":"Endarterectomy for asymptomatic carotid artery stenosis: executive committee for the asymptomatic carotid atherosclerosis study","volume":"23","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.molmet.2021.101337_bib23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaneurol.2020.1427","article-title":"Comparative effectiveness of carotid endarterectomy vs initial medical therapy in patients with asymptomatic carotid stenosis","volume":"77","author":"Keyhani","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.molmet.2021.101337_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphar.2019.00362","article-title":"Canagliflozin inhibits human endothelial cell proliferation and tube formation","volume":"10","author":"Behnammanesh","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.molmet.2021.101337_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcjd.2019.01.005","article-title":"Minimizing hyperglycemia-induced vascular endothelial dysfunction by inhibiting endothelial sodium-glucose cotransporter 2 and attenuating oxidative stress: implications for treating individuals with type 2 diabetes","volume":"43","author":"Pulakazhi Venu","year":"2019","journal-title":"Canadian Journal of Diabetes"},{"key":"10.1016\/j.molmet.2021.101337_bib26","first-page":"875","article-title":"Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice","volume":"15","author":"Ganbaatar","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2021.101337_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00125-016-4158-2","article-title":"The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE (-\/-) mice fed a western diet","volume":"60","author":"Han","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.molmet.2021.101337_bib28","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/jcmm.14233","article-title":"Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence","volume":"24","author":"Benkhiat","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.molmet.2021.101337_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4254\/wjh.v12.i7.350","article-title":"Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling","volume":"12","author":"Suga","year":"2020","journal-title":"World Journal of Hepatology"},{"key":"10.1016\/j.molmet.2021.101337_bib30","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1039\/c3mb00001j","article-title":"Sirtuin 6: a review of biological effects and potential therapeutic properties","volume":"9","author":"Beauharnois","year":"2013","journal-title":"Molecular BioSystems"},{"key":"10.1016\/j.molmet.2021.101337_bib31","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun","volume":"18","author":"Sundaresan","year":"2012","journal-title":"Natura Med"},{"key":"10.1016\/j.molmet.2021.101337_bib32","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2741\/4055","article-title":"Endothelial progenitor cells in atherosclerosis","volume":"17","author":"Du","year":"2012","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.molmet.2021.101337_bib33","first-page":"597514","article-title":"Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells","author":"Lappas","year":"2012","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.molmet.2021.101337_bib34","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.292.15.1845","article-title":"Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke","volume":"292","author":"Spagnoli","year":"2004","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.molmet.2021.101337_bib35","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.molmet.2021.101337_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.diabres.2019.02.014","article-title":"Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure","volume":"150","author":"Sinha","year":"2019","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.molmet.2021.101337_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/eurheartj\/ehs393","article-title":"Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox","volume":"34","author":"Niccoli","year":"2013","journal-title":"European Heart Journal"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:29:31Z","timestamp":1761956971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821001848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"alternative-id":["S2212877821001848"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101337","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101337"}}